Skip to main content
NAGE logo

NAGE · Niagen Bioscience, Inc. · Proposed Sales

Track NAGE — free
$3.05 -0.05 (-1.61%) At close · Sep 9
Market Cap
$242.01M
Shares
79.13M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2024-12-13 Frank Jaksch Jr. 37,161
2024-08-23 Kristin Patrick 23,000
Showing 1–2 of 2 filings
Key facts CIK 1386570 CUSIP 171077407 13F (30d) 88 filings 88 filers Visit website Investor relations